Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine (PPM - Pro)

NCT03527238 PHASE2 COMPLETED Results posted

Clinical trial applying Phenotypic Precision Medicine (PPM) to tacrolimus dosing in liver and/or kidney transplant recipients to show improvement in maintaining drug trough levels within the target range.

Details

Lead sponsor	University of Florida
Phase	PHASE2
Status	COMPLETED
Enrolment	62
Start date	Fri Sep 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Liver Transplant
• Kidney Transplant

Interventions

• PPM-based Computation Assisted Drug Dosing
• Tacrolimus

Countries

Singapore, United States